cholestyramine resin has been researched along with Myocardial Infarction in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (69.57) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, Y | 1 |
| Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
| BLACKET, RB; BROWN, WD; WOODHILL, J | 1 |
| Barthel, U; Haller, H; Hanefeld, M; Hora, C; Rothe, G; Schulze, J | 1 |
| Avila, MC; Chimeno Viñas, MM; del Campo, F; García-Robayna, H; Ortiz de Murúa, JA; Villafranca, JL; Zuazola, P | 1 |
| Bönner, G | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Linderer, T; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Hunger, R; Kuklinski, B; Marek, H | 1 |
| Eisenberg, JM; Kinosian, BP | 1 |
| Rifkind, BM | 1 |
| Hjermann, I | 1 |
| Miller, WW | 1 |
| Kronmal, RA | 1 |
| Pepper, GA | 1 |
| Chase, HP; Porter, KA; Putnam, CW; Starzl, TE | 1 |
| Fallat, RW; Glueck, CJ; Tsang, RC | 1 |
| Bavina, MV; Koropova, GI; Lobova, NM; Perova, NV | 1 |
| Flegel, U; Irsigler, K | 1 |
2 review(s) available for cholestyramine resin and Myocardial Infarction
| Article | Year |
|---|---|
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
[Acute postpartal myocardial infarct: the role of methylergometrin in its etiopathogenesis].
Topics: Adult; Anticoagulants; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Methylergonovine; Myocardial Infarction; Puerperal Disorders | 1994 |
4 trial(s) available for cholestyramine resin and Myocardial Infarction
| Article | Year |
|---|---|
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Prospective Studies; Treatment Outcome | 1999 |
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome | 2000 |
The Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Death, Sudden; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction | 1986 |
Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Random Allocation; Research Design; Statistics as Topic | 1985 |
17 other study(ies) available for cholestyramine resin and Myocardial Infarction
| Article | Year |
|---|---|
Bounds on controlled direct effects under monotonic assumptions about mediators and confounders.
Topics: Algorithms; Biometry; Cholestyramine Resin; Confounding Factors, Epidemiologic; Coronary Disease; Humans; Male; Middle Aged; Models, Statistical; Myocardial Infarction; Placebos; Prognosis; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2010 |
THE EFFECT OF CHOLESTYRAMINE ("MK 135") ON THE SERUM CHOLESTEROL LEVEL IN MAN.
Topics: Angina Pectoris; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Leg; Male; Myocardial Infarction; Pharmacology; Statistics as Topic; Thyroxine; Toxicology; Vascular Diseases; Xanthomatosis | 1964 |
Reduced incidence of cardiovascular complications and mortality in hyperlipoproteinemia (HLP) with effective lipid correction. The Dresden HLP study.
Topics: Adolescent; Adult; Cerebrovascular Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Combined Modality Therapy; Dietary Fats; Drug Therapy, Combination; Germany, East; Humans; Hyperlipoproteinemias; Middle Aged; Myocardial Infarction; Niacin; Physical Exertion; Triglycerides | 1984 |
[Care Study. Secondary prevention after myocardial infarct in moderately elevated total cholesterol].
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Diet, Fat-Restricted; Humans; Hyperlipidemias; Myocardial Infarction; Pravastatin; Risk Factors; Survival Rate | 1997 |
Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
Topics: Anticholesteremic Agents; Bezafibrate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Female; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Male; Myocardial Infarction; Pravastatin; Treatment Outcome | 1999 |
[Indications, contraindications and adverse effects of drugs in cardiovascular diseases. Treatment of hyperlipoproteinemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hyperlipidemias; Myocardial Infarction; Nicotinic Acids | 1977 |
Dextrothyroxine for lowering cholesterol.
Topics: Angina Pectoris; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Myocardial Infarction; Nicotinic Acids | 1976 |
Lipid-lowering drugs.
Topics: Cellulose; Cholestyramine Resin; Clofibrate; Drug Evaluation; Humans; Hyperlipidemias; Lipids; Myocardial Infarction; Neomycin; Nicotinic Acids | 1975 |
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking | 1988 |
Multiple risk factor intervention in coronary heart disease.
Topics: Adult; Anticholesteremic Agents; Behavior Therapy; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Death, Sudden; Finland; Humans; Hypertension; Male; Middle Aged; Myocardial Infarction; Norway; Risk; Smoking Prevention; World Health Organization | 1985 |
Preventive cardiology for coronary artery disease.
Topics: Cholestyramine Resin; Combined Modality Therapy; Coronary Disease; Humans; Hyperlipidemias; Hypertension; Lipids; Myocardial Infarction; Obesity; Physical Exertion; Risk; Smoking Prevention; Uric Acid | 1985 |
Preventing myocardial infarction: cholestyramine (Questran) and other hypolipidemics.
Topics: Cholestyramine Resin; Constipation; Humans; Hypercholesterolemia; Hypolipidemic Agents; Kinetics; Myocardial Infarction; Nurse Practitioners; Patient Education as Topic | 1986 |
Diet and coronary heart disease.
Topics: Adult; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Male; Middle Aged; Myocardial Infarction | 1985 |
Portacaval shunt in hyperlipoproteinaemia.
Topics: Acute Disease; Angina Pectoris; Aortic Valve Stenosis; Biopsy; Child; Child, Preschool; Cholestyramine Resin; Diet Therapy; Female; Follow-Up Studies; Heart Failure; Homozygote; Humans; Hypercholesterolemia; Infant; Lipoproteins; Lipoproteins, LDL; Liver; Microscopy, Electron; Myocardial Infarction; Portacaval Shunt, Surgical; Triglycerides; Xanthogranuloma, Juvenile | 1973 |
Hypercholesterolemia and hypertriglyceridemia in children.
Topics: Adolescent; Adult; Arteriosclerosis; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Diet, Reducing; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Lipids; Lipoproteins; Myocardial Infarction; Phenotype; Triglycerides | 1974 |
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Electrophoresis, Polyacrylamide Gel; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipid Mobilization; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Phospholipids; Sitosterols; Triglycerides | 1973 |
[Antilipidemic agents].
Topics: Adult; Alcohols; Anticholesteremic Agents; Biguanides; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hyperemia; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Nicotinic Acids; Thyroxine | 1971 |